Two Sigma Securities’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,054
Closed -$31K 3476
2022
Q3
$31K Buy
26,054
+13,309
+104% +$20.7K ﹤0.01% 2253
2022
Q2
$23K Sell
12,745
-69,297
-84% -$102K ﹤0.01% 1942
2022
Q1
$166K Buy
82,042
+46,115
+128% +$90.6K 0.01% 1759
2021
Q4
$97K Buy
+35,927
New +$133K ﹤0.01% 1186
2020
Q4
Sell
-18,320
Closed -$92.7K 2039
2020
Q3
$107K Buy
+18,320
New +$110K ﹤0.01% 1178
2019
Q3
Sell
-28,173
Closed -$419K 2571
2019
Q2
$419K Buy
+28,173
New +$509K ﹤0.01% 1235
2019
Q1
Sell
-11,786
Closed -$212K 2589
2018
Q4
$212K Buy
+11,786
New +$241K ﹤0.01% 1676
2017
Q3
Sell
-11,100
Closed -$1.04M 1292
2017
Q2
$1.04M Buy
+11,100
New +$679K 0.2% 91
2016
Q3
Sell
-10,042
Closed -$138K 817
2016
Q2
$138K Buy
+10,042
New +$147K 0.08% 298

Other funds holding CLVS